Research progress in prognostic biomarkers of liver failure
10.3760/cma.j.issn.1008-6315.2020.01.018
- VernacularTitle: 评估肝衰竭预后的生物学标志物研究进展
- Author:
Jie QIAO
1
;
Rongqi WANG
;
Yuemin NAN
Author Information
1. Hepatology Department of integrated traditional Chinese and western medicine, The Third Hospital of Hebei Medical University, Shijiazhuang 050000, China
- Publication Type:Review
- Keywords:
Liver failure;
Prognosis;
Neutrophil/lymphocyte ratio;
Golgi protein 73;
Human β
-defensin-1
- From:
Clinical Medicine of China
2020;36(1):80-83
- CountryChina
- Language:Chinese
-
Abstract:
Liver failure is a group of serious clinical syndrome, which develops rapidly and has a dangerous prognosis.In recent years, there are many biomarkers to evaluate the prognosis of patients with liver failure at home and abroad, such as neutrophil/lymphocyte ratio, alpha fetoprotein, galactose lectin-3, osteopontin, Golgi protein 73, human β - defensin-1, etc.these biomarkers are of great significance for early identification of patients with liver failure, accurate evaluation of their prognosis, and formulation of effective treatment plan.
